Cresset Asset Management, LLC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 54 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.54 and the average weighting 1.8%.

Quarter-by-quarter ownership
Cresset Asset Management, LLC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$30,000
+76.5%
26,0000.0%0.00%
Q2 2022$17,000
-75.0%
26,0000.0%0.00%
-100.0%
Q1 2022$68,000
-32.7%
26,0000.0%0.00%0.0%
Q4 2021$101,000
-7.3%
26,000
+4.0%
0.00%0.0%
Q3 2021$109,000
+10.1%
25,0000.0%0.00%0.0%
Q2 2021$99,00025,0000.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders